Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

A novel crystal form of cabergoline, form L.

Ham Z, Svete P, Urleb U, Darko K.

Acta Chim Slov. 2011 Sep;58(3):492-500.

PMID:
24062109
[PubMed]
2.

Physical characterization of pantoprazole sodium hydrates.

Zupancic V, Ograjsek N, Kotar-Jordan B, Vrecer F.

Int J Pharm. 2005 Mar 3;291(1-2):59-68. Epub 2004 Dec 29.

PMID:
15707732
[PubMed - indexed for MEDLINE]
3.

Influence of polymer content on stabilizing milled amorphous salbutamol sulphate.

Balani PN, Wong SY, Ng WK, Widjaja E, Tan RB, Chan SY.

Int J Pharm. 2010 May 31;391(1-2):125-36. doi: 10.1016/j.ijpharm.2010.02.029. Epub 2010 Mar 6.

PMID:
20211717
[PubMed - indexed for MEDLINE]
4.

Solid state characterization of dehydroepiandrosterone.

Chang LC, Caira MR, Guillory JK.

J Pharm Sci. 1995 Oct;84(10):1169-79.

PMID:
8801330
[PubMed - indexed for MEDLINE]
5.

Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods.

Li Y, Yang DJ, Chen SL, Chen SB, Chan AS.

Pharm Res. 2008 Mar;25(3):563-77. Epub 2007 Sep 8.

PMID:
17828444
[PubMed - indexed for MEDLINE]
6.

Comparative studies of mononuclear Ni(II) and UO2(II) complexes having bifunctional coordinated groups: synthesis, thermal analysis, X-ray diffraction, surface morphology studies and biological evaluation.

Fahem AA.

Spectrochim Acta A Mol Biomol Spectrosc. 2012 Mar;88:10-22. doi: 10.1016/j.saa.2011.11.037. Epub 2011 Dec 10.

PMID:
22197356
[PubMed - indexed for MEDLINE]
7.

Preformulation investigation of some clopidogrel addition salts.

Zupančič V, Smrkolj M, Benkič P, Simonič I, Plevnik M, Ritlop G, Kristl A, Vrečer F.

Acta Chim Slov. 2010 Jun;57(2):376-85.

PMID:
24061734
[PubMed]
8.

Salt screening and characterization for poorly soluble, weak basic compounds: case study albendazole.

Paulekuhn GS, Dressman JB, Saal C.

Pharmazie. 2013 Jul;68(7):555-64.

PMID:
23923637
[PubMed - indexed for MEDLINE]
9.

Rapid assessment of the structural relaxation behavior of amorphous pharmaceutical solids: effect of residual water on molecular mobility.

Miller DP, Lechuga-Ballesteros D.

Pharm Res. 2006 Oct;23(10):2291-305. Epub 2006 Sep 6.

PMID:
16955371
[PubMed - indexed for MEDLINE]
10.

Physical characterization of solid iopanoic acid forms.

Stagner WC, Guillory JK.

J Pharm Sci. 1979 Aug;68(8):1005-9.

PMID:
480153
[PubMed - indexed for MEDLINE]
11.

Characterization of the solubility and dissolution properties of several new rifampicin polymorphs, solvates, and hydrates.

Henwood SQ, Liebenberg W, Tiedt LR, Lötter AP, de Villiers MM.

Drug Dev Ind Pharm. 2001 Nov;27(10):1017-30.

PMID:
11794804
[PubMed - indexed for MEDLINE]
12.

Characterization of a novel polymorphic form of celecoxib.

Lu GW, Hawley M, Smith M, Geiger BM, Pfund W.

J Pharm Sci. 2006 Feb;95(2):305-17.

PMID:
16369929
[PubMed - indexed for MEDLINE]
13.

Characterization of two polymorphs of lornoxicam.

Zhang J, Tan X, Gao J, Fan W, Gao Y, Qian S.

J Pharm Pharmacol. 2013 Jan;65(1):44-52. doi: 10.1111/j.2042-7158.2012.01573.x. Epub 2012 Aug 5.

PMID:
23215687
[PubMed - indexed for MEDLINE]
14.

Novel furosemide cocrystals and selection of high solubility drug forms.

Goud NR, Gangavaram S, Suresh K, Pal S, Manjunatha SG, Nambiar S, Nangia A.

J Pharm Sci. 2012 Feb;101(2):664-80. doi: 10.1002/jps.22805. Epub 2011 Nov 11.

PMID:
22081478
[PubMed - indexed for MEDLINE]
15.

Phase transformation in conformational polymorphs of nimesulide.

Sanphui P, Sarma B, Nangia A.

J Pharm Sci. 2011 Jun;100(6):2287-99. doi: 10.1002/jps.22464. Epub 2011 Jan 14.

PMID:
21491446
[PubMed - indexed for MEDLINE]
16.

Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.

Basavoju S, Boström D, Velaga SP.

Pharm Res. 2008 Mar;25(3):530-41. Epub 2007 Aug 17.

PMID:
17703346
[PubMed - indexed for MEDLINE]
17.

Solid-state characterization of novel active pharmaceutical ingredients: cocrystal of a salbutamol hemiadipate salt with adipic acid (2:1:1) and salbutamol hemisuccinate salt.

Paluch KJ, Tajber L, Elcoate CJ, Corrigan OI, Lawrence SE, Healy AM.

J Pharm Sci. 2011 Aug;100(8):3268-83. doi: 10.1002/jps.22569. Epub 2011 Apr 6.

PMID:
21472730
[PubMed - indexed for MEDLINE]
18.

Crystal modifications and dissolution rate of piroxicam.

Lyn LY, Sze HW, Rajendran A, Adinarayana G, Dua K, Garg S.

Acta Pharm. 2011 Dec;61(4):391-402. doi: 10.2478/v10007-011-0037-z.

PMID:
22202198
[PubMed - indexed for MEDLINE]
19.

Polymorphism of diflunisal: isolation and solid-state characteristics of a new crystal form.

Martínez-Ohárriz MC, Martín C, Goñi MM, Rodríguez-Espinosa C, Tros de Ilarduya-Apaolaza MC, Sánchez M.

J Pharm Sci. 1994 Feb;83(2):174-7.

PMID:
8169784
[PubMed - indexed for MEDLINE]
20.

Physical and thermal characterisation of chiral omeprazole sodium salts.

Markovic N, Agotonovic-Kustrin S, Glass B, Prestidge CA.

J Pharm Biomed Anal. 2006 Sep 11;42(1):25-31. Epub 2006 Mar 9.

PMID:
16524682
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk